FeRiva 21/7
Product Overview
Brand: Avion Pharmaceuticals
Net Contents: N/A
Serving Size (Overview): 1 Tablet(s)
Product Type: Other Combinations [A1325]
Form: Tablet or Pill [E0155]
Date Entered: Nov 21, 2020
Market Status: On Market
Suggested Use (Overview): Dosage and Administration: Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider. The FeRiva 21/7 Tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple inert tablets. Take 1 red iron tablet daily for 21 days; followed by 1 purple inert tablet daily for 7 days. After 28 tablets have been taken a new course maybe started if prescribed.
Product Self-Roles:
- No specific self-roles defined.
Dietary Supplement Facts
| Ingredient | Category | Amount Per Serving | Unit | % Daily Value | Target Group | Serving Size (Fact) |
|---|---|---|---|---|---|---|
| Vitamin C | vitamin | 175 | mg | 292 | Adults and children 4 or more years of age | 1 Tablet(s) |
| Vitamin C | vitamin | 175 | mg | 292 | Pregnant and Lactating | 1 Tablet(s) |
| Zinc | mineral | 10 | mg | 67 | Adults and children 4 or more years of age | 1 Tablet(s) |
| Zinc | mineral | 10 | mg | 67 | Pregnant and Lactating | 1 Tablet(s) |
| Vitamin B12 | vitamin | 12 | mcg | 200 | Adults and children 4 or more years of age | 1 Tablet(s) |
| Vitamin B12 | vitamin | 12 | mcg | 150 | Pregnant and Lactating | 1 Tablet(s) |
| Iron | mineral | 75 | mg | 417 | Adults and children 4 or more years of age | 1 Tablet(s) |
| Iron | mineral | 75 | mg | 417 | Pregnant and Lactating | 1 Tablet(s) |
| Folate | vitamin | 1 | mg | 250 | Adults and children 4 or more years of age | 1 Tablet(s) |
| Folate | vitamin | 1 | mg | 125 | Pregnant and Lactating | 1 Tablet(s) |
| Folic Acid | vitamin | 400 | mcg | N/A | N/A | 1 Tablet(s) |
| Succinic Acid | non-nutrient/non-botanical | 150 | mg | N/A | Adults and children 4 or more years of age | 1 Tablet(s) |
| Succinic Acid | non-nutrient/non-botanical | 150 | mg | N/A | Pregnant and Lactating | 1 Tablet(s) |
Other Ingredients
Other Ingredients (Red Iron Tablets) (Coating Contains; and Croscarmellose Sodium; Dicalcium Phosphate; Magnesium Stearate; Microcrystalline Cellulose; Silicon Dioxide; Stearic Acid); Other Ingredients (Purple Inert Tablets) (Coating Contains; Croscarmellose Sodium; Dicalcium Phosphate; and Magnesium Stearate; Microcrystalline Cellulose; Silicon Dioxide; Stearic Acid)
Label Statements
Other
- RX Only How Supplied: FeRiva 21/7 tablets blister pack (75854+318-28) contains 21 red iron tablets and 7 purple inert tablets. The listed product number is not a National Drug Code. Instead Avion Pharmaceuticals has assigned a product code formatted according to standard industry practice to meet the formatting requirements of pharmacy and health insurance computer systems.
Statement of Identity
- Dietary Supplement These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose treat cure or prevent any disease.
Formulation
- Description: FeRiva 21/7 tablets for oral administration is a 28-day iron supplement regiment that consists of 21 red oval-shaped iron tablets and 7 purple oval-shaped inert tablets. Each red oval-shaped iron tablet is debossed with '21' and '7' separated by a line in the middle on the top-side of the tablet and blank on the other side. Each purple oval shaped inert tablet is blank on both sides of the tablet. Purple Inert Tablets do not contain any vitamins minerals or other dietary ingredients. Please see other ingredients section below for the listing of the inert ingredients. Indications: FeRiva 21/7 is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
Precautions
- Contraindications: FeRiva 21/7 is contraindicated in patients with a known hypersensitivity to any of the ingredients. Hemochromatosis and hemosiderosis are contraindicated to iron therapy. Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose call a doctor or poison control center immediately. Precautions: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. While prescribing this nutritional supplement for pregnant women nursing mothers or for women prior to conception their medical condition and other drugs herbs and/or supplements consumption should be considered. Adverse Reactions: Allergic sensitization has been reported following both oral and parenteral administration of folic acid. Keep out of reach of children.
Suggested Use
- Dosage and Administration: Usual dosage is one tablet daily with or without food or as prescribed by your healthcare provider. The FeRiva 21/7 Tablets blister pack supplies a 28-day course of iron therapy that consists of 21 red iron tablets and 7 purple inert tablets. Take 1 red iron tablet daily for 21 days followed by 1 purple inert tablet daily for 7 days. After 28 tablets have been taken a new course maybe started if prescribed.
Product Specific Information
- Store betweed 20 degrees; 25 degrees C (68 degrees; 77 degrees F).
Branding Statement(s)
- Sumalate is a registered trademark of Albion Laboratories Inc. covered by one or more claims of U.S. Patent Nos. 6716814 8007846 and 8425956.
Associated Company Information & Roles
Avion Pharmaceuticals LLC
No address details available for this company.
Roles for this Product:
- Manufacturer